Custom Synthesis

Peptide-oligonucleotide conjugates (POCs) have emerged as an innovative class of chimeric therapeutics that integrate the exceptional sequence specificity of nucleic […]

What is the Scope of a CRO in IND-Enabling Studies for Peptide Oligonucleotide Conjugates? A specialized Contract Research Organization (CRO)

Introduction: GMP manufacturing of peptide-oligonucleotide conjugates sits at the intersection of two highly complex chemistries — and getting it right

Introduction: Peptide-Oligonucleotide Conjugates Impurity Profiling plays a critical role in the development of next-generation therapeutics such as antisense oligonucleotides, RNA

Introduction The comparison of Peptide vs Antibody Oligonucleotide Conjugates has become an important topic in the development of modern oligonucleotide

Introduction: The primary therapeutic advantage of Peptide Oligonucleotide Conjugates Drug Delivery lies in its ability to enable precise, extrahepatic tissue

Introduction: Peptide-oligonucleotide conjugates (POCs) require carefully controlled strategies to remain stable because they combine two sensitive components—peptides and nucleic acids.

Introduction The Challenges in Peptide Oligonucleotide Conjugates development arise mainly from the complexity of combining peptides with nucleic acids into

Introduction Peptide Oligonucleotide Conjugate Synthesis Methods have become increasingly important as peptide–oligonucleotide conjugates (POCs) gain attention in nucleic acid therapeutics,